Claritev Corp 8-K

What Happened Claritev Corporation (CTEV) filed an 8-K on June 22, 2026, updating investors that the Antitrust Division of the U.S. Department of Justice informed the company on June 17, 2026 that an antitrust grand jury proceeding tied to a subpoena issued in August 2024 is being brought to a close and that the company is not under any criminal investigation. The company also noted it received a civil investigative demand from the Antitrust Division on May 19, 2026 and is cooperating with requests for information.

Key Details

• August 2024: Claritev received a confidential grand jury subpoena from the DOJ Antitrust Division related to a health insurance investigation.
• May 19, 2026: Company received a civil investigative demand from the DOJ and is cooperating.
• June 17, 2026: DOJ informed Claritev the grand jury proceeding is being closed and Claritev is not under criminal investigation.
• 8-K filed June 22, 2026, furnishing this Regulation FD disclosure to investors.

Why It Matters This update resolves the criminal aspect of the DOJ’s grand jury review — the company is not under criminal investigation — which reduces one legal overhang for investors. However, the outstanding civil investigative demand means Claritev remains subject to a civil inquiry and must continue to cooperate with the DOJ, which could still require management time and resources. Investors should watch for further disclosures about the civil inquiry or any material impacts on operations or financials.